Literature DB >> 10975209

The rise and fall of troglitazone.

C J Bailey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10975209     DOI： 10.1046/j.1464-5491.2000.00315.x

Source DB:  PubMed          Journal:  Diabet Med        ISSN： 0742-3071            Impact factor:   4.359


× No keyword cloud information.
  5 in total

1.  Thiazolidinediones for type 2 diabetes. New agents reduce insulin resistance but need long term clinical trials.

Authors:  A J Krentz; C J Bailey; A Melander
Journal:  BMJ       Date:  2000-07-29

Review 2.  Hepatotoxicity with thiazolidinediones: is it a class effect?

Authors:  A J Scheen
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 3.  New pharmacologic agents for diabetes.

Authors:  C J Bailey
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

Review 4.  Nonalcoholic fatty liver disease: a review and update.

Authors:  Jeffrey R Lewis; Smruti R Mohanty
Journal:  Dig Dis Sci       Date:  2010-01-26       Impact factor: 3.199

Review 5.  Interpreting adverse signals in diabetes drug development programs.

Authors:  Clifford J Bailey
Journal:  Diabetes Care       Date:  2013-05-21       Impact factor: 19.112
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.